The EU's vaccine strategy - the key points

The European Commission, on behalf of member states, has sealed deals with six companies for up to 2.3 billion vaccine doses. The BioNTech-Pfizer and Moderna vaccines are so far the only jabs authorised in the EU, but the vaccine jointly developed by Oxford and AstraZeneca is expected to be approved on Friday (29 January) by the European Medical Agency (EMA).

With two doses per person needed for both authorised vaccines, the EU could vaccinate at least 380 million people - covering approximately 80 percent of the European population.

Read more at: https://euobserver.com/coronavirus/150747